References
- Anderson T J. Mitotic and apoptotic response of breast tissue to oral contraceptives. Lancet 1984; i: 99–100
- Andersson T J., Ferguson D JP, Raab G M. Cell turnover in the resting human breast: Influence of parity, contraceptive pill, age and laterality. Br J Cancer 1982; 46: 376–82
- Cohen S. The epidermal growht factor (EGF). Cancer 1983; 51: 1787–91
- Dailey G, Kraus J W., Orth D N. Homologous radioimmunoassay for human epidermal growth factor (uro-gastrone). J Clin Endocrinol Metab 1978; 46: 926–36
- Fitzpatrick S L., Brightwell J, Wittliff J L., Barrows G H., Schultz G S. Epidermal growth factor binding by breast tumour biopsies and relationship to estrogen receptor and progestin receptor levels. Cancer Res 1984; 44: 3448–53
- Going J J., Battersby S, Anderson T J., Raab G. Thymidine labelling in human breast parenchyma: effects of contraceptives use and menstrual cycle. J Pathol 1985; 146: 272A
- Gospodarowicz D. Growth factors and their action in vivo and in vitro. J Pathol 1983; 141: 201–34
- Manton S. PhD Thesis, University of Edinburgh. 1983
- McCarty K, Jr, Sasso R, Budwit D, Georgiade G S., Seigler H F. Immunoglobulin localization in the normal human mammary gland: variation with the menstrual cycle. Am J Path 1982; 107: 322–6
- McManus M J., Welsch C W. The effect of estrogen, progesterone, thyroxine and human placental lactogen in DNA synthesis of human breast ductal epithelium maintained in athymic nude mice. Cancer 1984; 54: 1920–7
- Meyer J S. Cell proliferation in normal human breast ducts, fibroadenomas and other ductal hyperplastic measured by nuclear labelling with tritiated thymidine. Hum Pathol 1977; 8: 67–81
- Miller W, Loudon N, Personal communication
- Mukherji M. BSc (Med Sci) Thesis, University of Edinburgh. 1983
- Ozzello L, Speer F D. The mucopolysaccharides of normal and diseased breasts. Their distribution and significance. Am J Pathol 1958; 34: 993–1009
- Pike M C., Henderson B E., Krailo M D., Duke A. Breast cancer in young women and use of oral contraceptives: possible modifying of formulation and age at use. Lancet 1983; ii: 936–938
- Royal College of General Practitioners' Report. Oral contraceptives and Health. Pitman Medical. 1974; 35
- Sainsbury J RC, Farndon J R., Harris A L., Sherbet G V. Epidermal growth factor receptors in human breast cancer. Br J Surg 1985; 72: 186–8
- Theele C, Bassler R. Size distribution, forms and variations of glandular tissue of the breast. Histometric studies on the question of the effect of oral contraceptives on the lobular parenchyma. Pathologe 1981; 2: 208–19
- Thomas D B. Do hormones cause cancer?. Cancer 1984; 53(Suppl)595–604
- Ulstein M, Myklebust R. Ultrastructure of cervical mucus and sperm penetration during use of a triphase oral contraceptive. Acta Obstet Gynecol Scand 1982, Suppl 105: 45–50
- Vogel P, Georgiade N G., Fetter B F., Vogel F S., McKarty K S., Jr. The correlation of histologic changes in the human breast with the menstrual cycle. Am J Pathol, 104: 23–34
- Welsch C W., McManus M J. Stimulation of DNA synthesis by human placental lactogen or insulin in organ cultures of benign human breast tumours. Cancer Res 1977; 37: 2257–61
- Wyllie A H., Kerr J FR, Currie A R. Cell death: the significance of apoptosis. Int Rev Cytol 1980; 68: 251–356
- Zacharie F, Thorsoe H. Hormonal control of acid mucopolysacchardies in the female genital tract. Hormones and Connective Tissue, G Asboe-Hanson. Munksgaard, Copenhagen 1966; 257